ABILIFY INJ. Products Affected Step 2: ABILIFY MAINTENA PREFILLED SYRINGE 300 MG INTRAMUSCULAR ABILIFY MAINTENA PREFILLED SYRINGE 400 MG INTRAMUSCULAR
|
|
- Colleen Shields
- 5 years ago
- Views:
Transcription
1 ABILIFY INJ ABILIFY MAINTENA PREFILLED SYRINGE 300 MG ABILIFY MAINTENA PREFILLED SYRINGE 400 MG ABILIFY MAINTENA SUSPENSION RECONSTITUTED ER 300 MG Claim will pay automatically for ABILIFY MAINTENA if enrollee has a paid claim for at least a 1 days supply of a Latuda AND aripiprazole in the past 365 days. Otherwise, require a step therapy exception request indicating any ONE of the following: (1) History of inadequate treatment response with Latuda or aripiprazole, OR (2) history of adverse event with Latuda, OR (3)Latuda is contraindicated. 1
2 ANTICONVULSANTS APTIOM TABLET 200 MG APTIOM TABLET 400 MG APTIOM TABLET 600 MG APTIOM TABLET 800 MG BANZEL SUSPENSION 40 MG/ML BANZEL TABLET 200 MG BANZEL TABLET 400 MG BRIVIACT SOLUTION 10 MG/ML BRIVIACT TABLET 10 MG BRIVIACT TABLET 100 MG BRIVIACT TABLET 25 MG BRIVIACT TABLET 50 MG BRIVIACT TABLET 75 MG CELONTIN CAPSULE 300 MG FYCOMPA SUSPENSION 0.5 MG/ML FYCOMPA TABLET 10 MG FYCOMPA TABLET 12 MG FYCOMPA TABLET 2 MG FYCOMPA TABLET 4 MG FYCOMPA TABLET 6 MG FYCOMPA TABLET 8 MG ONFI SUSPENSION 2.5 MG/ML ONFI TABLET 10 MG ONFI TABLET 20 MG PEGANONE TABLET 250 MG SPRITAM TABLET DISINTEGRATING SOLUBLE 1000 MG SPRITAM TABLET DISINTEGRATING SOLUBLE 250 MG SPRITAM TABLET DISINTEGRATING SOLUBLE 500 MG SPRITAM TABLET DISINTEGRATING SOLUBLE 750 MG VIMPAT SOLUTION 10 MG/ML VIMPAT SOLUTION 200 MG/20ML INTRAVENOUS VIMPAT TABLET 150 MG VIMPAT TABLET 200 MG VIMPAT TABLET 50 MG Claim will pay automatically for Brand Anticonvulsants if enrollee has a paid claim for at least a 1 days supply of a Generic Anticonvulsant in the past 365 days. Otherwise, Brand Anticonvulsants require a step therapy exception request indicating: (1) history of inadequate treatment response with Generic Anticonvulsants, OR (2) history of adverse event with Generic Anticonvulsants, OR (3)Generic Anticonvulsants is contraindicated. 2
3 ANTIDEPRESSANTS amoxapine tablet 100 mg oral amoxapine tablet 150 mg oral amoxapine tablet 25 mg oral amoxapine tablet 50 mg oral citalopram hydrobromide solution 10 mg/5ml oral citalopram hydrobromide tablet 10 mg oral citalopram hydrobromide tablet 20 mg oral citalopram hydrobromide tablet 40 mg oral EMSAM PATCH 24 HOUR 12 MG/24HR TRANSDERMAL EMSAM PATCH 24 HOUR 6 MG/24HR TRANSDERMAL EMSAM PATCH 24 HOUR 9 MG/24HR TRANSDERMAL MARPLAN TABLET 10 MG TRINTELLIX TABLET 10 MG TRINTELLIX TABLET 20 MG TRINTELLIX TABLET 5 MG VIIBRYD STARTER PACK KIT 10 & 20 MG VIIBRYD TABLET 10 MG VIIBRYD TABLET 20 MG VIIBRYD TABLET 40 MG Claim will pay automatically for MARPLAN, EMSAM, AMOXAPINE, VIIBRYD, CITALOPRAM, OR TRINTELLIX if enrollee has a paid claim for at least a 1 days supply of MIRTAZAPINE, PHENELZINE SULFATE, TRANYLCYPROMINE SULFATE, NEFAZODONE HCL, TRAZODONE HCL, ESCITALOPRAM OXALATE, FLUOXETINE HCL, FLUVOXAMINE MALEATE, PAROXETINE HCL, PAXIL SUS, SERTRALINE HCL, DESVENLAFAXINE ER, DULOXETINE HCL, FETZIMA, FETZIMA TITRATION PACK, VENLAFAXINE HCL, VENLAFAXINE HCL ER, AMITRIPTYLINE HCL, DESIPRAMINE HCL, DOXEPIN HCL, IMIPRAMINE HCL, PROTRIPTYLINE HCL, MAPROTILINE HCL, BUPROPION HCL, BUPROPION HCL SR, or BUPROPION HCL XL in the past 365 days. Otherwise, MARPLAN, EMSAM, AMOXAPINE, VIIBRYD, CITALOPRAM OR TRINTELLIX require a step therapy exception request indicating: (1) history of inadequate treatment response with Step 1 Antidepressant, OR (2) history of adverse event with Step 1 Antidepressant, OR (3)Step 1 Antidepressant is contraindicated. 3
4 ATELVIA ATELVIA TABLET DELAYED RELEASE 35 MG Claim will pay automatically for Atelvia if enrollee has a paid claim for at least a 1 days supply of Alendronate, Ibandronate or Risedroante in the past 365 days. Otherwise, Atelvia requires a step therapy exception request indicating: (1) history of inadequate treatment response with Alendronate, Ibandronate or Risedroante, OR (2) history of adverse event with Alendronate, Ibandronate or Risedroante, OR (3) Alendronate, Ibandronate or Risedroante is contraindicated. 4
5 ATYPICALS ABILIFY MAINTENA PREFILLED SYRINGE 300 MG ABILIFY MAINTENA PREFILLED SYRINGE 400 MG ABILIFY MAINTENA SUSPENSION RECONSTITUTED ER 300 MG clozapine tablet 100 mg oral clozapine tablet 200 mg oral clozapine tablet dispersible 100 mg oral clozapine tablet dispersible 12.5 mg oral clozapine tablet dispersible 150 mg oral clozapine tablet dispersible 200 mg oral clozapine tablet dispersible 25 mg oral FANAPT TABLET 1 MG FANAPT TABLET 10 MG FANAPT TABLET 12 MG FANAPT TABLET 2 MG FANAPT TABLET 4 MG FANAPT TABLET 6 MG FANAPT TABLET 8 MG FANAPT TITRATION PACK TABLET 1 & 2 & 4 & 6 MG FAZACLO TABLET DISPERSIBLE 100 MG FAZACLO TABLET DISPERSIBLE 12.5 MG FAZACLO TABLET DISPERSIBLE 150 MG FAZACLO TABLET DISPERSIBLE 200 MG FAZACLO TABLET DISPERSIBLE 25 MG GEODON SOLUTION RECONSTITUTED 20 MG INVEGA SUSTENNA SUSPENSION 117 MG/0.75ML 5 INVEGA SUSTENNA SUSPENSION 156 MG/ML INVEGA SUSTENNA SUSPENSION 234 MG/1.5ML INVEGA SUSTENNA SUSPENSION 39 MG/0.25ML INVEGA SUSTENNA SUSPENSION 78 MG/0.5ML INVEGA TRINZA SUSPENSION 273 MG/0.875ML INVEGA TRINZA SUSPENSION 410 MG/1.315ML INVEGA TRINZA SUSPENSION 546 MG/1.75ML INVEGA TRINZA SUSPENSION 819 MG/2.625ML NUPLAZID TABLET 17 MG RISPERDAL CONSTA SUSPENSION RECONSTITUTED 12.5 MG RISPERDAL CONSTA SUSPENSION RECONSTITUTED 25 MG RISPERDAL CONSTA SUSPENSION RECONSTITUTED 37.5 MG RISPERDAL CONSTA SUSPENSION RECONSTITUTED 50 MG SAPHRIS TABLET SUBLINGUAL 10 MG SUBLINGUAL SAPHRIS TABLET SUBLINGUAL 2.5 MG SUBLINGUAL SAPHRIS TABLET SUBLINGUAL 5 MG SUBLINGUAL VERSACLOZ SUSPENSION 50 MG/ML VRAYLAR CAPSULE 1.5 MG VRAYLAR CAPSULE 3 MG
6 VRAYLAR CAPSULE 4.5 MG VRAYLAR CAPSULE 6 MG VRAYLAR CAPSULE THERAPY PACK 1.5 & 3 MG ZYPREXA RELPREVV SUSPENSION RECONSTITUTED 210 MG Claim will pay automatically for ABILIFY MAINTENNA, CLOZAPINE TABLET (NON-ODT), INVEGA (SUSTENNA/TRINZA), NUPLAZID, ZYPREXA RELPREVV, FANAPT, FANAPT TITRATION PACK, RISPERDAL CONSTA, VERSACLOZ, CLOZAPINE ODT, FAZACLO, SAPHRIS, NUPLAZID, GEODON,VRAYLAR if enrollee has a paid claim for at least a 1 days supply of a Latuda OR 2 GENERIC AGENTS( ARIPIPRAZOLE, CHLORPROMAZINE, COMPRO, FLUPHENAZINE, HALOPERIDOL, LOXAPINE, OLANZAPINE, PALIPERIDONE, PERPHENAZINE, PROCHLORPERAZINE, QUETIAPINE, RISPERDONE, THIORIDAZINE, THIOTHIXENE, TRIFLUOPERAZINE, or ZIPRASIDONE) in the past 365 days. Otherwise, Non-Preferred Antipsychotics require a step therapy exception request indicating any ONE of the following (1) diagnosis that is not covered by Latuda (i.e. Acute treatment of agitation for Geodon injection), OR (2)history of inadequate treatment response with Latuda, OR (3) history of adverse event with Latuda, OR (4)Latuda is contraindicated (5) diagnosis that is not covered by Nuplazid (i.e. Parkinson's disease psychosis) 6
7 CAPS ILARIS (150MG DELIVERED) SOLUTION RECONSTITUTED 180 MG SUBCUTANEOUS Claim will pay automatically for Ilaris if enrollee has a paid claim for at least a 1 days supply of Arcalyst in the past 365 days. Otherwise, Ilaris requires a step therapy exception request indicating: (1) diagnosis not covered by Arcalyst such as systemic juvenile idiopathic arthritis (2) history of inadequate treatment response with Arcalyst, OR (3) history of adverse event with Arcalyst OR (4) Arcalyst is contraindicated. 7
8 CNS STIMULANTS atomoxetine hcl capsule 10 mg oral atomoxetine hcl capsule 100 mg oral atomoxetine hcl capsule 18 mg oral atomoxetine hcl capsule 25 mg oral atomoxetine hcl capsule 40 mg oral atomoxetine hcl capsule 60 mg oral atomoxetine hcl capsule 80 mg oral Claim will pay automatically for ATOMOXETINE if enrollee has paid claims history for any one of the following formulary CNS stimulants: amphetamine salts, dexmethylphenidate, dextroamphetamine, methylphenidate OR guanfacine ER. Otherwise, ATOMOXETINE requires a step therapy exception request indicating: (1) history of inadequate treatment response with amphetamine salts, dexmethylphenidate, dextroamphetaminemethylphenidate, OR guanfacine ER OR (2) history of adverse event with amphetamine salts, dexmethylphenidate, dextroamphetamine, methylphenidate, OR guanfacine ER OR (3)amphetamine salts, dexmethylphenidate, dextroamphetamine, methylphenidate OR guanfacine ER is contraindicated. 8
9 ELIDEL ELIDEL CREAM 1 % EXTERNAL Claim will pay automatically for Elidel if enrollee has paid claims history for at least 2 different formulary topical steroids. 9
10 FENTANYL fentanyl patch 72 hour 100 mcg/hr fentanyl patch 72 hour 12 mcg/hr fentanyl patch 72 hour 25 mcg/hr fentanyl patch 72 hour 37.5 mcg/hr fentanyl patch 72 hour 50 mcg/hr fentanyl patch 72 hour 62.5 mcg/hr fentanyl patch 72 hour 75 mcg/hr fentanyl patch 72 hour 87.5 mcg/hr Claim will pay automatically for Fentanyl patches if enrollee has paid claims history of any 1 days supply in the past 365 days of Morphine ER, Methadone, morphine oral solution OR buprenorphine patches. Otherwise, the drug requires a step therapy exception request indicating any ONE of the following: (1) history of inadequate treatment response with Morphine ER, Methadone, morphine oral solution OR buprenorphine patches, OR (2) history of adverse event with Morphine ER, Methadone, morphine oral solution OR buprenorphine patches, OR (3) Morphine ER, Methadone, morphine oral solution OR buprenorphine patches are contraindicated. 10
11 RANEXA RANEXA TABLET EXTENDED RELEASE 12 HOUR 1000 MG RANEXA TABLET EXTENDED RELEASE 12 HOUR 500 MG Claim will pay automatically for RANEXA if enrollee has a paid claim for at least a 1 day supply of AMLODIPINE, ATENOLOL, DILTIAZEM, ISOSORBIDE DINITRATE, ISOSORBIDE MONONITRATE, METOPROLOL, NADOLOL, NICARDIPINE, NITROGLYCERIN, PROPRANOLOL in the past 365 days. Otherwise RANEXA requires a step therapy exception request indication any ONE of the following: (1) history of inadequate treatment response with step 1 agents or (2) history of adverse event with a step 1 agent or (3) step 1 agents are contraindicated. 11
12 ULORIC ULORIC TABLET 40 MG ULORIC TABLET 80 MG Claim will pay automatically for Uloric if enrollee has a paid claim for at least a 1 days supply of Allopurinol in the past 365 days. Otherwise, Uloric requires a step therapy exception request indicating: (1) history of inadequate treatment response with Allopurinol, OR (2) history of adverse event with Allopurinol, OR (3) Allopurinol is contraindicated. 12
13 Alphabetical Listing A ABILIFY MAINTENA PREFILLED SYRINGE 300 MG... 1, 5 ABILIFY MAINTENA PREFILLED SYRINGE 400 MG... 1, 5 ABILIFY MAINTENA SUSPENSION RECONSTITUTED ER 300 MG... 1, 5 amoxapine tablet 100 mg oral... 3 amoxapine tablet 150 mg oral... 3 amoxapine tablet 25 mg oral... 3 amoxapine tablet 50 mg oral... 3 APTIOM TABLET 200 MG... 2 APTIOM TABLET 400 MG... 2 APTIOM TABLET 600 MG... 2 APTIOM TABLET 800 MG... 2 ATELVIA TABLET DELAYED RELEASE 35 MG... 4 atomoxetine hcl capsule 10 mg oral... 8 atomoxetine hcl capsule 100 mg oral... 8 atomoxetine hcl capsule 18 mg oral... 8 atomoxetine hcl capsule 25 mg oral... 8 atomoxetine hcl capsule 40 mg oral... 8 atomoxetine hcl capsule 60 mg oral... 8 atomoxetine hcl capsule 80 mg oral... 8 B BANZEL SUSPENSION 40 MG/ML... 2 BANZEL TABLET 200 MG... 2 BANZEL TABLET 400 MG... 2 BRIVIACT SOLUTION 10 MG/ML... 2 BRIVIACT TABLET 10 MG... 2 BRIVIACT TABLET 100 MG... 2 BRIVIACT TABLET 25 MG... 2 BRIVIACT TABLET 50 MG... 2 BRIVIACT TABLET 75 MG... 2 C CELONTIN CAPSULE 300 MG... 2 citalopram hydrobromide solution 10 mg/5ml oral citalopram hydrobromide tablet 10 mg oral 3 citalopram hydrobromide tablet 20 mg oral 3 citalopram hydrobromide tablet 40 mg oral 3 clozapine tablet 100 mg oral... 5 clozapine tablet 200 mg oral... 5 clozapine tablet dispersible 100 mg oral... 5 clozapine tablet dispersible 12.5 mg oral... 5 clozapine tablet dispersible 150 mg oral... 5 clozapine tablet dispersible 200 mg oral... 5 clozapine tablet dispersible 25 mg oral... 5 E ELIDEL CREAM 1 % EXTERNAL... 9 EMSAM PATCH 24 HOUR 12 MG/24HR TRANSDERMAL... 3 EMSAM PATCH 24 HOUR 6 MG/24HR TRANSDERMAL... 3 EMSAM PATCH 24 HOUR 9 MG/24HR TRANSDERMAL... 3 F FANAPT TABLET 1 MG... 5 FANAPT TABLET 10 MG... 5 FANAPT TABLET 12 MG... 5 FANAPT TABLET 2 MG... 5 FANAPT TABLET 4 MG... 5 FANAPT TABLET 6 MG... 5 FANAPT TABLET 8 MG... 5 FANAPT TITRATION PACK TABLET 1 & 2 & 4 & 6 MG... 5 FAZACLO TABLET DISPERSIBLE 100 MG... 5 FAZACLO TABLET DISPERSIBLE 12.5 MG... 5 FAZACLO TABLET DISPERSIBLE 150 MG... 5 FAZACLO TABLET DISPERSIBLE 200 MG... 5 FAZACLO TABLET DISPERSIBLE 25 MG... 5 fentanyl patch 72 hour 100 mcg/hr fentanyl patch 72 hour 12 mcg/hr... 10
14 fentanyl patch 72 hour 25 mcg/hr fentanyl patch 72 hour 37.5 mcg/hr fentanyl patch 72 hour 50 mcg/hr fentanyl patch 72 hour 62.5 mcg/hr fentanyl patch 72 hour 75 mcg/hr fentanyl patch 72 hour 87.5 mcg/hr FYCOMPA SUSPENSION 0.5 MG/ML... 2 FYCOMPA TABLET 10 MG... 2 FYCOMPA TABLET 12 MG... 2 FYCOMPA TABLET 2 MG... 2 FYCOMPA TABLET 4 MG... 2 FYCOMPA TABLET 6 MG... 2 FYCOMPA TABLET 8 MG... 2 G GEODON SOLUTION RECONSTITUTED 20 MG... 5 I ILARIS (150MG DELIVERED) SOLUTION RECONSTITUTED 180 MG SUBCUTANEOUS... 7 INVEGA SUSTENNA SUSPENSION 117 MG/0.75ML... 5 INVEGA SUSTENNA SUSPENSION 156 MG/ML... 5 INVEGA SUSTENNA SUSPENSION 234 MG/1.5ML... 5 INVEGA SUSTENNA SUSPENSION 39 MG/0.25ML... 5 INVEGA SUSTENNA SUSPENSION 78 MG/0.5ML... 5 INVEGA TRINZA SUSPENSION 273 MG/0.875ML... 5 INVEGA TRINZA SUSPENSION 410 MG/1.315ML... 5 INVEGA TRINZA SUSPENSION 546 MG/1.75ML... 5 INVEGA TRINZA SUSPENSION 819 MG/2.625ML M MARPLAN TABLET 10 MG... 3 N NUPLAZID TABLET 17 MG... 5 O ONFI SUSPENSION 2.5 MG/ML.. 2 ONFI TABLET 10 MG... 2 ONFI TABLET 20 MG... 2 P PEGANONE TABLET 250 MG... 2 R RANEXA TABLET EXTENDED RELEASE 12 HOUR 1000 MG 11 RANEXA TABLET EXTENDED RELEASE 12 HOUR 500 MG. 11 RISPERDAL CONSTA SUSPENSION RECONSTITUTED 12.5 MG... 5 RISPERDAL CONSTA SUSPENSION RECONSTITUTED 25 MG... 5 RISPERDAL CONSTA SUSPENSION RECONSTITUTED 37.5 MG... 5 RISPERDAL CONSTA SUSPENSION RECONSTITUTED 50 MG... 5 S SAPHRIS TABLET SUBLINGUAL 10 MG SUBLINGUAL... 5 SAPHRIS TABLET SUBLINGUAL 2.5 MG SUBLINGUAL... 5 SAPHRIS TABLET SUBLINGUAL 5 MG SUBLINGUAL... 5 SPRITAM TABLET DISINTEGRATING SOLUBLE 1000 MG... 2 SPRITAM TABLET DISINTEGRATING SOLUBLE 250 MG... 2 SPRITAM TABLET DISINTEGRATING SOLUBLE 500 MG... 2 SPRITAM TABLET DISINTEGRATING SOLUBLE 750 MG... 2 T TRINTELLIX TABLET 10 MG... 3 TRINTELLIX TABLET 20 MG... 3
15 TRINTELLIX TABLET 5 MG... 3 U ULORIC TABLET 40 MG ULORIC TABLET 80 MG V VERSACLOZ SUSPENSION 50 MG/ML... 5 VIIBRYD STARTER PACK KIT 10 & 20 MG... 3 VIIBRYD TABLET 10 MG... 3 VIIBRYD TABLET 20 MG... 3 VIIBRYD TABLET 40 MG... 3 VIMPAT SOLUTION 10 MG/ML. 2 VIMPAT SOLUTION 200 MG/20ML INTRAVENOUS... 2 VIMPAT TABLET 150 MG... 2 VIMPAT TABLET 200 MG... 2 VIMPAT TABLET 50 MG... 2 VRAYLAR CAPSULE 1.5 MG... 5 VRAYLAR CAPSULE 3 MG... 5 VRAYLAR CAPSULE 4.5 MG... 6 VRAYLAR CAPSULE 6 MG... 6 VRAYLAR CAPSULE THERAPY PACK 1.5 & 3 MG... 6 Z ZYPREXA RELPREVV SUSPENSION RECONSTITUTED 210 MG
**CRITERIA UNDER CMS REVIEW**
**CRITERIA UNDER CMS REVIEW** ANTICONVULSANTS APTIOM TABLET 200 MG APTIOM TABLET 400 MG APTIOM TABLET 600 MG APTIOM TABLET 800 MG BANZEL SUSPENSION 40 MG/ML BANZEL TABLET 200 MG BANZEL TABLET 400 MG BRIVIACT
More informationANTICONVULSANTS. Details. Step Therapy Criteria Date Effective: April 1, 2019
Step Therapy Date Effective: April 1, 2019 ANTICONVULSANTS APTIOM TABLET 200 MG ORAL APTIOM TABLET 400 MG ORAL APTIOM TABLET 600 MG ORAL APTIOM TABLET 800 MG ORAL BANZEL SUSPENSION 40 MG/ML ORAL BANZEL
More informationANTIDEPRESSANTS. Details. Step Therapy 2018 Last Updated: 8/21/2018
ANTIDEPRESSANTS EMSAM PATCH 24 HOUR 12 MG/24HR TRANSDERMAL EMSAM PATCH 24 HOUR 6 MG/24HR TRANSDERMAL EMSAM PATCH 24 HOUR 9 MG/24HR TRANSDERMAL FETZIMA CAPSULE EXTENDED RELEASE 24 HOUR 120 MG ORAL FETZIMA
More informationANTIDEPRESSANTS. Details. Step Therapy 2017 Last Updated: 5/23/2017
ANTIDEPRESSANTS EMSAM PATCH 24 HOUR 12 MG/24HR TRANSDERMAL EMSAM PATCH 24 HOUR 6 MG/24HR TRANSDERMAL EMSAM PATCH 24 HOUR 9 MG/24HR TRANSDERMAL FETZIMA CAPSULE EXTENDED RELEASE 24 HOUR 120 MG FETZIMA CAPSULE
More informationU T I L I Z A T I O N E D I T S
I N D I A N A H E A L T H C O V E R A G E P R O G R A M S U T I L I Z A T I O N E D I T S A P R I L 1 9, 2 0 1 2 s for s Refer to Provider Bulletin BT200709 for additional information regarding the Mental
More informationTexas Prior Authorization Program Clinical Edit Criteria
Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Clinical Edit Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization
More informationAntipsychotics Prior Authorization Criteria for Louisiana Fee for Service and MCO Medicaid Recipients
Antipsychotics Prior Authorization Criteria for Louisiana Fee for Service and MCO Medicaid Recipients Preferred Agents (Oral) a Amitriptyline/Perphenazine (Generic) Aripiprazole Tablet (Generic) b Chlorpromazine
More informationDrugs requiring prior authorization: the list of drugs requiring prior authorization for this clinical criteria
Drug/Drug Class Antipsychotics Clinical Criteria Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization for this clinical criteria Prior
More informationStep Therapy Medications
Step Therapy Medications Step Therapy Group APTIOM Step-2: APTIOM 200 MG TABLET or APTIOM 400 MG TABLET or APTIOM 600 MG TABLET or APTIOM 800 MG TABLET Step 1 Drug(s): Oxcarbazepine immediate-release,
More informationFirstCarolinaCare Insurance Company. Step Therapy Requirements
FirstCarolinaCare Insurance Company Step Therapy Requirements Effective: 12/01/2018 ANTICONVULSANTS APTIOM 200 MG APTIOM 400 MG APTIOM 600 MG APTIOM 800 MG BANZEL 200 MG BANZEL 40 MG/ML ORAL SUSPENSION
More informationANTICONVULSANTS. Details
ANTICONVULSANTS APTIOM 200 MG TABLET APTIOM 400 MG TABLET APTIOM 600 MG TABLET APTIOM 800 MG TABLET BANZEL 200 MG TABLET BANZEL 40 MG/ML ORAL SUSPENSION BANZEL 400 MG TABLET FYCOMPA 0.5 MG/ML ORAL SUSPENSION
More informationSanta Clara Family Health Plan Cal MediConnect Formulary. List of Step Therapy Requirements Effective: 12/01/ E
Santa Clara Family Health Plan Cal MediConnect Formulary List of Step Therapy Requirements Effective: 12/01/2018 13027.12E ANTICONVULSANTS APTIOM 200 MG TABLET APTIOM 400 MG TABLET APTIOM 600 MG TABLET
More informationANTICONVULSANTS. Details
ANTICONVULSANTS Aptiom 200 mg tablet Aptiom 400 mg tablet Aptiom 600 mg tablet Aptiom 800 mg tablet Banzel 200 mg tablet Banzel 40 mg/ml oral suspension Banzel 400 mg tablet Fycompa 0.5 mg/ml oral suspension
More informationARISTADA. Products Affected Step 2: ARISTADA PREFILLED SYRINGE 1064 MG/3.9ML INTRAMUSCULAR ARISTADA PREFILLED SYRINGE 441 MG/1.
ARISTADA ARISTADA PREFILLED SYRINGE 1064 MG/3.9ML INTRAMUSCULAR ARISTADA PREFILLED SYRINGE 441 MG/1.6ML INTRAMUSCULAR ARISTADA PREFILLED SYRINGE 662 MG/2.4ML INTRAMUSCULAR ARISTADA PREFILLED SYRINGE 882
More informationStep Therapy Group. Atypical Antipsychotic Agents
Atypical Antipsychotic Agents Any beneficiary newly enrolled into Community Care, Inc. currently receiving aripiprazole, aripiprazole ODT, risperidone, risperidone ODT, olanzapine, olanzapine ODT, quetiapine,
More informationJudges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children
Judges Reference Table for the Psychotropic Medication Utilization Parameters for Foster Children Stimulants for treatment of ADHD Preschool (Ages 3-5 years) Child (Ages 6-12 years) Adolescent (Ages 13-17
More informationAMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details
AMANTADINE ER OSMOLEX ER 129 MG, EXTENDED RELEASE OSMOLEX ER 193 MG, EXTENDED RELEASE OSMOLEX ER 258 MG, EXTENDED RELEASE PRIOR CLAIM FOR AMANTADINE HCL IMMEDIATE RELEASE WITHIN THE PAST 120 DAYS. 1 ANTICONVULSANTS
More informationStep Therapy Requirements
Step Therapy Requirements Denver Health Medicare Choice (HMO SNP)/Medicare Select (HMO) Effective: 09/01/2017 Updated 08/2017 ANTICONVULSANTS Aptiom 200 mg tablet Aptiom 400 mg tablet Aptiom 600 mg tablet
More informationANTICONVULSANTS. Details
ANTICONVULSANTS Aptiom 200 mg tablet Aptiom 400 mg tablet Aptiom 600 mg tablet Aptiom 800 mg tablet Banzel 200 mg tablet Banzel 40 mg/ml oral suspension Banzel 400 mg tablet Fycompa 0.5 mg/ml oral suspension
More informationOhana Community Care Services (CCS) Comprehensive Preferred Drug List (List of Covered Drugs)
2015 Ohana Community Care Services (CCS) Comprehensive referred Drug List (List of Covered Drugs) Ohana Health lan 00 lease read: This document contains information about the drugs we cover in this plan.
More informationANTICONVULSANTS. Details
ANTICONVULSANTS APTIOM 200 MG APTIOM 400 MG APTIOM 600 MG APTIOM 800 MG BANZEL 200 MG BANZEL 40 MG/ML ORAL SUSPENSION BANZEL 400 MG FYCOMPA 0.5 MG/ML ORAL SUSPENSION FYCOMPA 10 MG FYCOMPA 12 MG FYCOMPA
More informationVNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017
VNSNY CHOICE FIDA Complete Step Therapy Requirements Effective: 01/01/2017 Updated 12/23/2016 ANTICONVULSANTS Aptiom 200 mg tablet Potiga 200 mg tablet Aptiom 400 mg tablet Potiga 300 mg tablet Aptiom
More informationMedications and Children Disorders
Mental Health Comprehensive Services Providing Family Stability and Developing Life Coping Skills Medications and Children Disorders Psychiatric medications can be an effective part of the treatment for
More information2015 Step Therapy Prior Authorization Medical Necessity Guidelines
Tufts Health Unify 2015 Step Therapy Prior Authorization Medical Necessity Guidelines Effective: 01/01/2015 Updated: 10/01/2015 Tufts Health Plan P.O. Box 9194 Watertown, MA 02471-9194 Phone: 855-393-3154
More informationALAMEDA COUNTY BEHAVIORAL HEALTH CARE SERVICES MEDICATION FORMULARY
ANTIDEPRESSANTS Serotonin Selective Reuptake Inhibitors citalopram 10, 20, 40 mg, 10 mg/5cc $ 0.40 No escitalopram 10, 20 mg $ 2.60 Yes fluoxetine 10, 20 mg, 20 mg/5 ml $ 0.40 Yes fluvoxamine 25, 50, 100
More informationPharmacy Benefit Management (PBM) Program FORMULARY/PRODUCT RESTRICTIONS
Workforce Safety & Insurance Revised Document Date: 07/21/2015 1600 E Century Ave Ste 1 PO Box 5585 Bismarck, ND 58506-5585 701.328.3800 1.800.777.5033 www.workforcesafety.com Pharmacy Benefit Management
More informationA Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer
A Brief Overview of Psychiatric Pharmacotherapy Joel V. Oberstar, M.D. Chief Executive Officer Disclosures Some medications discussed are not approved by the FDA for use in the population discussed/described.
More informationGranite Alliance Insurance Company (PDP) 2018 Step Therapy Criteria Last Updated: 10/23/18
Granite Alliance Insurance Company (PDP) 2018 Step Therapy Criteria Last Updated: 10/23/18 Granite Alliance requires step therapy for certain drugs. This means prior to receiving a drug with a step therapy
More informationIMPORTANT NOTICE. Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members
IMPORTANT NOTICE Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members These changes apply only to members covered under the DC Healthcare Alliance program Alliance
More informationCRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication.
ADHD STIMULANTS ATOMOXETINE HCL, DEXEDRINE 10 MG TABLET, DEXEDRINE 5 MG TABLET, DEXMETHYLPHENIDATE HCL, DEXMETHYLPHENIDATE HCL ER, DEXTROAMPHETAMINE 10 MG TAB, DEXTROAMPHETAMINE 5 MG TAB, DEXTROAMPHETAMINE
More informationAMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details
AMANTADINE ER OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, EXTENDED RELEASE OSMOLEX ER 258 MG TABLET, PRIOR CLAIM FOR AMANTADINE HCL IMMEDIATE RELEASE WITHIN THE PAST 120 DAYS.
More informationAppendix: Psychotropic Medication Reference Tables
Appendix: Psychotropic Medication Reference Tables How to Use these Tables These reference tables are designed to provide clinic staff with specific medication related criteria for the Polypharmacy, Cardiometabolic
More informationVNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017
Effective: 01/01/2017 Updated 11/2016 ANTI-INFLAMMATORY AGENTS - GI DIPENTUM PRIOR CLAIM FOR BALSALAZIDE OR APRISO WITHIN THE PAST 120 DAYS. ANTICONVULSANTS APTIOM BANZEL FYCOMPA GABITRIL OXTELLAR XR POTIGA
More informationAttention: Behavioral Health Providers, Pharmacists and Prescribers N.C. Medicaid and N.C. Health Choice Preferred Drug List Changes - UPDATE
Attention: Behavioral Health Providers, Pharmacists and Prescribers N.C. Medicaid and N.C. Health Choice Drug List Changes - UPDATE Note: This article was previously published in the December 2014 Medicaid
More informationStep Therapy Requirements. Effective: 1/1/2019
Effective: 1/1/2019 Updated 1/2019 AMANTADINE ER Sharp Health Plan (HMO) OSMOLEX ER 129 MG, EXTENDED RELEASE OSMOLEX ER 193 MG, EXTENDED RELEASE OSMOLEX ER 258 MG, EXTENDED RELEASE PRIOR CLAIM FOR AMANTADINE
More informationDIFICID. Products Affected Step 2: DIFICID TABLET 200 MG ORAL. Details
DIFICID DIFICID TABLET 200 MG ORAL Claim will pay automatically for Dificid if enrollee has a paid claim for at least a 1 days supply of vancomycin in the past. Otherwise, Dificid requires a step therapy
More informationStep Therapy Requirements. Effective: 03/01/2015
Effective: 03/01/2015 Updated 02/2015 ANTI-INFLAMMATORY AGENTS - GI DIPENTUM PRIOR CLAIM FOR BALSALAZIDE OR APRISO WITHIN THE PAST 120 DAYS. ANTICONVULSANTS APTIOM BANZEL FYCOMPA OXTELLAR XR POTIGA QUDEXY
More informationVNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 04/01/2019
VNSNY CHOICE FIDA Complete Step Therapy Requirements Effective: 04/01/2019 Updated 03/2019 AMANTADINE ER OSMOLEX ER 129 MG, EXTENDED RELEASE OSMOLEX ER 193 MG, EXTENDED RELEASE OSMOLEX ER 258 MG, EXTENDED
More informationAntipsychotic Medications Age and Step Therapy
Market DC *- Florida Healthy Kids Antipsychotic Medications Age and Step Therapy Override(s) Approval Duration Prior Authorization 1 year Quantity Limit *Virginia Medicaid See State Specific Mandates *Indiana
More informationAMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details
AMANTADINE ER OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, EXTENDED RELEASE OSMOLEX ER 258 MG TABLET, PRIOR CLAIM FOR AMANTADINE HCL IMMEDIATE RELEASE WITHIN THE PAST 120 DAYS.
More informationSimply Step Therapy Document September 2018 Y0114_18_33074_I_009
2018 2018 Simply Step Therapy Document September 2018 Aptiom APTIOM 200 MG TABLET APTIOM 400 MG TABLET Y0114_18_33074_I_009 APTIOM 600 MG TABLET APTIOM 800 MG TABLET Criteria If the patient has tried a
More informationANTIDEPRESSANTS. Details. dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet. Criteria
ANTIDEPRESSANTS Trintellix 10 mg tablet Trintellix 20 mg tablet Trintellix 5 mg tablet Viibryd 10 mg (7)-20 mg (23) tablets in a dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet
More informationStep Therapy Requirements. Effective: 11/01/2018
Effective: 11/01/2018 Updated 10/2018 ANTIDEPRESSANTS Sharp Health Plan (HMO) TRINTELLIX 10 MG TABLET TRINTELLIX 20 MG TABLET TRINTELLIX 5 MG TABLET VIIBRYD 10 MG (7)-20 MG (23) TABLETS IN A DOSE PACK
More informationPharmacy Medical Necessity Guidelines: Antipsychotic Medications
Pharmacy Medical Necessity Guidelines: Effective: October 1, 2016 Prior Authorization Required Type of Review Care Management Not Covered Type of Review Clinical Review Pharmacy (RX) or Medical (MED) Benefit
More informationStep Therapy Requirements. Effective: 05/01/2018
Step Therapy Requirements Effective: 05/01/2018 ANTIDEPRESSANTS TRINTELLIX 10 MG TABLET TRINTELLIX 20 MG TABLET TRINTELLIX 5 MG TABLET VIIBRYD 10 MG (7)-20 MG (23) TABLETS IN A DOSE PACK VIIBRYD 10 MG
More informationCENPATICO INTEGRATED CARE BEHAVIORAL HEALTH DRUG LIST BY DRUG NAME. Use Brand Only
ACAMPROSATE TABLET DELAYED RELEASE ALPHA-TOCOPHEROL CAPSULES ALPRAZOLAM CONCENTRATE 1 MG/ML ALPRAZOLAM ODT TABLET 0.25MG, 0.5MG, 1MG ALPRAZOLAM ODT TABLET 2MG ALPRAZOLAM SR TABLET 24-HOUR ALPRAZOLAM TABLET
More informationHarvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO), Stride SM Value Rx Plus (HMO) and Stride SM Gain Rx (HMO)
Harvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO), Stride SM Value Rx Plus (HMO) and Stride SM Gain Rx (HMO) Step Therapy Requirements Effective 4/1/2019 Updated 3/2019 BRAND
More information2019 PDP Basic Step Therapy Document
Aggrenox 2019 PDP Basic Step Therapy Document AGGRENOX 25 MG-200 MG CAPSULE, EXTENDED aspirin 25 mg-dipyridamole 200 mg capsule,ext.release 12 hr multiphase drug may be given. Step 1 Drug(s): clopidigrel.
More informationPharmacy Medical Necessity Guidelines: Antipsychotic Medications
Pharmacy Medical Necessity Guidelines: Effective: April 1, 2018 Prior Authorization Required Type of Review Care Management Not Covered Type of Review Clinical Review Pharmacy (RX) or Medical (MED) Benefit
More informationMO Medicaid Foster Care Drugs FY10-FY14
MO Medicaid Foster Care Drugs FY10-FY14 Medicaid (MO HealthNet) Cost of Drugs given to Missouri Foster Care Children by combinations of Age, Gender, Drug Class and Fiscal Year [Raw Data Provided by Missouri
More informationNorthSTAR. Pharmacy Manual
NorthSTAR Pharmacy Manual Revised October, 2008 Table of I. Introduction II. III. IV. Antidepressants New Generation Antipsychotic Medications Mood Stabilizers V. ADHD Medications VI. Anxiolytics and Sedative-Hypnotics
More informationADHD STIMULANTS-S(SHC)
Step Therapy Simply Health Care 2014 Formulary ID: 14406 Version: 14 Last Updated: 08/01/2014 ADHD STIMULANTS-S(SHC) Daytrana Focalin Xr Strattera Patient needs to have a paid claim for one Step 1 drug
More informationCARE N CARE HEALTH PLAN
PPI DEXILANT CAPSULE DELAYED RELEASE 30 MG ORAL DEXILANT CAPSULE DELAYED RELEASE 60 MG ORAL Claim will pay automatically for Dexilant if enrollee has a paid claim for at least a 1 days supply of lansoprazole,
More informationALLERGIC CONJUNCTIVITIS AGENTS
2018 5 Tier Standard- Keystone First VIP Choice Document: 2018 Step Therapy Formulary ID: 18390 Last Updated: 04/2018 Effective Date: 05-01-2018 ALLERGIC CONJUNCTIVITIS AGENTS epinastine 0.05 % eye drops
More informationCONTRAINDICATIONS TABLE
CONTRAINDICATIONS TABLE Generic Name Brand Name Contraindications Amphetamine Salts Adderall, Adderall XR Hypersensitivity to amphetamine, dextroamphetamine, or other sympathomimetic amines Advanced arteriosclerosis
More informationANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY
South Country Health Alliance 2017 Step Therapy Formulary ID: 17431 Last Updated: 10/20/2017 Effective Date: 11-01-2017 ANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY BENICAR 20 MG BENICAR 40 MG BENICAR 5
More informationRelative Cost/Month. Less than $10. Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL*
Allergy Chlorpheniramine Tablet* Diphenhydramine Tablet* Diphenhydramine Liquid* Loratadine Tablet* Cetirizine Tablet* Loratadine 10mg ODT* Less than $10 Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL*
More information2019 Simply Step Therapy Document
Aggrenox 2019 Simply Step Therapy Document AGGRENOX 25 MG-200 MG CAPSULE, EXTENDED aspirin 25 mg-dipyridamole 200 mg capsule,ext.release 12 hr multiphase drug may be given. Step 1 Drug(s): clopidigrel.
More information2017 Step Therapy Criteria
FRESENIUS TOTAL HEALTH 2017 Step Therapy Updated 07/01/2017. For more recent information or other questions, please contact Fresenius Total Health Customer Service at 1-855-598-6774 / TTY 1-844-209-9094.
More informationANTIDIABETIC AGENTS - MISCELLANEOUS
ANTIDIABETIC AGENTS - MISCELLANEOUS Glyxambi 10 mg-5 mg tablet Glyxambi 25 mg-5 mg tablet Invokamet 150 mg-1,000 mg tablet Invokamet 150 mg-500 mg tablet Invokamet 50 mg-1,000 mg tablet Invokamet 50 mg-500
More informationPPHP 2017 Formulary 2017 Step Therapy Criteria
ARISTADA Aristada Prefilled Syringe 1064 MG/3.9ML Intramuscular Aristada Prefilled Syringe 441 MG/1.6ML Intramuscular Aristada Prefilled Syringe 662 MG/2.4ML Intramuscular Aristada Prefilled Syringe 882
More informationANTIDIABETIC AGENTS - MISCELLANEOUS
ANTIDIABETIC AGENTS - MISCELLANEOUS Glyxambi 10 mg-5 mg tablet Glyxambi 25 mg-5 mg tablet Invokamet 150 mg-1,000 mg tablet Invokamet 150 mg-500 mg tablet Invokamet 50 mg-1,000 mg tablet Invokamet 50 mg-500
More informationHarvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO) and Stride SM Value Rx Plus (HMO) Step Therapy Requirements
Harvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO) and Stride SM Value Rx Plus (HMO) Step Therapy Requirements Effective 7/1/2018 Updated 6/2018 BRAND NAME ANTIDEPRESSANTS APLENZIN
More informationANTIDIABETIC AGENTS - MISCELLANEOUS
ANTIDIABETIC AGENTS - MISCELLANEOUS GLYXAMBI 10 MG-5 MG GLYXAMBI 25 MG-5 MG INVOKAMET 150 MG-1,000 MG INVOKAMET 150 MG-500 MG INVOKAMET 50 MG-1,000 MG INVOKAMET 50 MG-500 MG INVOKAMET XR 150 MG-1,000 MG,
More informationReview of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course)
Review of Psychotrophic Medications (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Common Psychiatric Disorders *Schizophrenia *Depression *Bipolar Disorder
More informationCARE N CARE HEALTH PLAN
ARISTADA Aristada Prefilled Syringe 441 MG/1.6ML Intramuscular Aristada Prefilled Syringe 662 MG/2.4ML Intramuscular Aristada Prefilled Syringe 882 MG/3.2ML Intramuscular Claim will pay automatically for
More informationCARE N CARE HEALTH PLAN
ARISTADA ARISTADA PREFILLED SYRINGE 1064 MG/3.9ML INTRAMUSCULAR ARISTADA PREFILLED SYRINGE 441 MG/1.6ML INTRAMUSCULAR ARISTADA PREFILLED SYRINGE 662 MG/2.4ML INTRAMUSCULAR ARISTADA PREFILLED SYRINGE 882
More informationHEALTHTEAM ADVANTAGE 2018 Step Therapy Criteria
GLP1-INSULIN XULTOPHY SOLUTION PEN- INJECTOR 100-3.6 UNIT-MG/ML Claim will pay automatically for Xultophy if enrollee has a paid claim for at least a one day supply for step level 1 agent (LANTUS, LEVEMIR,
More informationAHCCCS BEHAVIORAL HEALTH DRUG LIST EFFECTIVE OCTOBER 1, 2016
Generic Drugs Are Preferred Over Brand Name Drugs Unless Specified As Brand Only Federally Reimbursable Drugs Not Listed On The AHCCCS Drug List Are Available Through Prior Authorization Effective Date
More informationHEALTHTEAM ADVANTAGE 2018 Step Therapy Criteria
GLP1-INSULIN XULTOPHY SOLUTION PEN- INJECTOR 100-3.6 UNIT-MG/ML HEALTHTEAM ADVANTAGE Claim will pay automatically for Xultophy if enrollee has a paid claim for at least a one day supply for step level
More information2018 PDP Premier Step Therapy Document September 2018 Y0114_18_33144_I_009
2018 PDP Premier Step Therapy Document September 2018 Aggrenox Y0114_18_33144_I_009 aspirin 25 mg-dipyridamole 200 mg capsule,ext.release 12 hr multiphase drug may be given. Step 1 Drug(s): clopidigrel.
More informationCommissioner for the Department for Medicaid Services Selections for Preferred Products
Commissioner for the Department for Medicaid Services Selections for Preferred Products This is a summary of the final Preferred Drug List (PDL) selections made by the Commissioner for the Department for
More informationHOSPITAL BASED INPATIENT PSYCHIATRIC SERVICES (HBIPS) MEASURE SET
HOSPITAL BASED INPATIENT PSYCHIATRIC SERVICES (HBIPS) MEASURE SET Kathy Wonderly RN, MSEd, CPHQ Consultant Developed: February, 2013 Most recently revised: December 2018 The Psychiatric Measure Set CMS
More informationALPHA GLUCOSIDASE INHIBITOR THERAPY
ALPHA GLUCOSIDASE INHIBITOR THERAPY GLYSET Step 1: One generic formulary product containing one of the following ingredients: glimeperide, glipizide, metformin or pioglitazone. Step 2: Glyset PAGE 1 LAST
More informationUse Brand Only. Preferred Drug Status PRIOR AUTHORIZATION REQUIRED
Generic Drugs Are Over Brand Drugs Unless Specified As Brand ANTIDEPRESSANTS ALPHA-2 RECEPTOR ANTAGONIST ANTIDEPRESSANTS MIRTAZAPINE REMERON 30 30 MIRTAZAPINE REMERON SOLTAB 30 30 ISOCARBOXAZID TABLETS
More informationDealing with a Mental Health Crisis
Dealing with a Mental Health Crisis Information and Resources for First Responders P... PROFESSIONAL WHAT NAMI DOES NAMI Minnesota is a statewide 501(c)(3) grassroots nonprofit organization dedicated to
More informationHEDIS BEHAVIORAL HEALTH RESOURCE GUIDE
HEDIS BEHAVIORAL HEALTH RESOURCE GUIDE What is HEDIS? 3 HEDIS Reference Guide for Behavioral Health 4 Behavioral Health HEDIS Measures 13 WHAT IS HEDIS? HEDIS (Healthcare Effectiveness Data and Information
More informationWELLCARE/ OHANA HEALTH PLAN 2015 STEP THERAPY CRITERIA (No Changes Made Since: 08/2015)
WELLCARE/ OHANA HEALTH PLAN 2015 STEP THERAPY CRITERIA (No Changes Made Since: 08/2015) **To get updated information about the drugs covered by WellCare/ Ohana, please visit our website (https://www.wellcare.com
More informationPsychotropic Medications Archana Jhawar, PharmD, BCPP Clinical Faculty of UIC Pharmacy Practice Clinical Psychiatric Pharmacist Jesse Brown VA
Psychotropic Medications Archana Jhawar, PharmD, BCPP Clinical Faculty of UIC Pharmacy Practice Clinical Psychiatric Pharmacist Jesse Brown VA Goals of Medications Use least number at lowest dose to get
More informationSchedule FDA & literature based indications
Psychotropic Medication List Recommended dosages are intended to serve only as a guide for children. Recommended doses are literature based. Clinicians should consult package insert of medications for
More informationPharmacy Medical Necessity Guidelines: Antipsychotic Medications
Pharmacy Medical Necessity Guidelines: Antipsychotic Medications Effective: July. 1, 2016 Prior Authorization Required Type of Review Care Management Not Covered Type of Review Clinical Review Pharmacy
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: (Invega Sustenna, Invega Trinza) Reference Number: CP.PHAR.291 Effective Date: 12.01.16 Last Review Date: 08.18 Line of Business: Medicaid See Important Reminder at the end of this policy
More information2018 Step Therapy Criteria
2018 Step Therapy Criteria ANGIOTENSIN RECEPTOR BLOCKERS... 2 ANTIDEPRESSANTS... 3 ANTIDEPRESSANTS, MISCELLANEOUS... 4 ANTIDEPRESSANTS, OTHER... 5 ANTIDIABETIC AGENTS... 6 ANTIGOUT AGENTS... 7 ANTIHYPERTENSIVE
More informationNuplazid (pimavanserin)
Texas Prior Authorization Program Clinical Criteria Drug/Drug Class This criteria was recommended for review by the Texas Medicaid Vendor Drug Program to ensure appropriate and safe utilization. Additional
More informationAvoid paying too much for your prescriptions
Quality health plans & benefits Healthier living Financial well-being Intelligent solutions 2017 Aetna Rx Step Program Medicine List Avoid paying too much for your prescriptions It s important to try to
More informationRexulti (brexpiprazole)
Market DC Rexulti (brexpiprazole) Override(s) Approval Duration Prior Authorization 1 year Quantity Limit *Indiana see State Specific Mandates below *Maryland see State Specific Mandates below *Virginia
More informationTexas Standard Prior Authorization Form Addendum
Texas Standard Prior Authorization Form Addendum Molina Healthcare of Texas Antipsychotics (Medicaid) This fax machine is located in a secure location as required by HIPAA Regulations. Complete / Review
More information2018 STEP THERAPY CRITERIA UCare Connect (SNBC) MinnesotaCare Prepaid Medical Assistance Program (PMAP) Minnesota Senior Care Plus (MSC+)
2018 STEP THERAPY CRITERIA UCare Connect (SNBC) MinnesotaCare Prepaid Medical Assistance Program (PMAP) Minnesota Senior Care Plus (MSC+) In some cases, UCare requires you to first try certain drugs to
More informationHCA BHS Prescribing Guidelines Committee - Approved Medications 2012
Amitriptyline/Perphenazine Triavil MAJOR TRANQUILIZERS Beneficiaries 10/2, 10/4, 25/2, 25/4, 50/4 Aripiprazole Abilify 2mg, 5mg, 10mg, 15mg, 20mg, 30mg Quantity Limit 31 / mo for Asenapine Saphris 5mg,
More informationMedicare Part D Drugs that Require Step Therapy Effective 12/01/2017
Medicare Part D Drugs that Require Step Therapy Effective 12/01/2017 Providers may call the Pharmacy Help Desk at 800-641-8921 for more information or questions about criteria. The formulary may change
More informationUSF Health Psychiatry Clinic. New Patient Questionnaire Adult
USF Health Psychiatry Clinic New Patient Questionnaire Adult Please mail or fax the completed forms to the address/fax number on the bottom of this page. Completed forms must be received five (5) days
More information